Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European stocks edged higher; eurozone inflation in focus

Published 2023-12-19, 03:22 a/m
Updated 2023-12-19, 03:22 a/m
© Reuters

Investing.com - European stock markets edged higher Tuesday, with investors awaiting the release of the latest eurozone inflation data as they start unwinding before the Christmas holidays. 

At 03:15 ET (08:15 GMT), the DAX index in Germany traded 0.3% higher, the CAC 40 in France traded up 0.1% and the FTSE 100 in the U.K. rose 0.3%.

Eurozone inflation in focus

The focus in Europe Tuesday will be on the release of the final reading of eurozone inflation for November, as investors try to figure out the future path of interest rates in the region.

Eurozone CPI is expected to be confirmed at an annual rate of 2.4% in November, a monthly drop of 0.5%, and not far removed from the European Central Bank’s 2% target.

The ECB kept interest rates unchanged last week, as widely expected, amid market speculation that the central bank’s prolonged rate-hiking cycle has come to an end and it would start cutting next year.

Policymakers at the ECB have been trying to rein in these expectations since last week’s meeting, with Slovenia's central bank governor Bostjan Vasle saying on Monday that the ECB will need at least until spring before it can reassess its policy outlook, adding market expectations for an interest rate cut in March or April are premature.

The Bank of Japan earlier Tuesday decided to leave its ultra-easy policy settings and dovish forward guidance unchanged.

Bayer (OTC:BAYRY) suffers legal setback

In corporate news, Bayer (ETR:BAYGN) stock rose 0.4% despite a U.S. jury ordered Monsanto (NYSE:MON), owned by the German chemicals giant, to pay $857 million to former students and parent volunteers of a U.S. school who claimed that chemicals made by the company made them ill. 

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Bayer announced plans to appeal.

UBS (SIX:UBSG) stock rose 1.5% after Cevian Capital announced it had taken a 1.3% stake in the Swiss banking giant, worth around €1.2 billion (€1 = $1.0931), with the activist investor group seeing "significant value potential" following its takeover of Credit Suisse (SIX:CSGN).

Crude stabilizes on naval task force plan

Oil prices stabilized Tuesday after the previous session’s gains, as the U.S. announced plans to expand a naval task force to protect shipping through the Red Sea (NYSE:SE).

By 03:15 ET, the U.S. crude futures traded 0.2% lower at $72.66 a barrel, while the Brent contract traded flat at $77.96 a barrel. 

Both benchmarks rose more than 1% on Monday on concerns about shippers diverting vessels away from the Red Sea, causing supply disruptions, in the face of an increase of assaults by Houthi militants in Yemen.

Additionally, gold futures fell 0.1% to $2,038.65/oz, while EUR/USD traded 0.1% higher at 1.0932.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.